Abstract:Objectives The present study estimated the percentage of rural Chinese adults with hypertension and recommended pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline compared with the 2010 Chinese Guideline for the Management of Hypertension. Design Cross-sectional study. Setting Three counties in rural areas of northeastern China. Participants A total of 11 747 eligible individuals aged ≥35 years from rural areas of northeastern China were selected for the present analysis. Main outcome measures The percentage of rural Chinese adults with hypertension and recommended pharmacological antihypertensive treatment according to the 2017 ACC/AHA guideline and the 2010 Chinese Guideline for the Management of Hypertension, and the proportion of rural Chinese adults taking antihypertensive medication with blood pressure (BP) above the 2017 ACC/AHA guideline and the 2010 Chinese guideline treatment goal. Results The mean age of the study population was 53.9±10.8 years and 53.7% of the participants were women. According to the 2017 ACC/AHA guideline and the 2010 Chinese guideline, the crude prevalence of hypertension was 72.2% and 49.8%, respectively, and the percentage of recommended antihypertensive medications for rural Chinese adults was 56.4% and 51.4%, respectively. Among these rural Chinese adults taking antihypertensive medications, 96.7% had above goal BP according to the 2017 ACC/AHA guideline compared with 86.1% with above goal BP according to the 2010 Chinese guideline. Conclusion The present analysis demonstrated that compared with the 2010 Chinese guideline, the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage of rural Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended antihypertensive medications. More intensive management is suggested to improve the control rate of hypertension among rural Chinese adults.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the potential impact of the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines on the prevalence of hypertension, the recommended antihypertensive drug treatment rate, and the proportion of blood pressure not reaching the target in rural areas of China. Specifically, the study compared the application effects of the 2017 ACC/AHA guidelines and the 2010 Chinese Hypertension Management Guidelines in rural areas of Liaoning province, aiming to explore the potential impact of the new guidelines on the local epidemiological characteristics of hypertension and prevention and treatment strategies. ### Main research contents: 1. **Changes in the definition of hypertension**: - According to the 2017 ACC/AHA guidelines, the definition of hypertension was adjusted from systolic blood pressure (SBP)/diastolic blood pressure (DBP) ≥ 140/90 mmHg to ≥ 130/80 mmHg. - This change led to a significant increase in the prevalence of hypertension. 2. **Comparison of the prevalence of hypertension**: - According to the 2010 Chinese guidelines, the prevalence of hypertension among adults in rural areas of Liaoning province was 49.8%. - According to the 2017 ACC/AHA guidelines, this proportion increased to 72.2%, an increase of 22.4%. 3. **Proportion of recommended antihypertensive drug treatment**: - According to the 2010 Chinese guidelines, the proportion of recommended antihypertensive drug treatment was 51.4%. - According to the 2017 ACC/AHA guidelines, this proportion increased to 56.4%, an increase of 5.0%. 4. **Proportion of blood pressure not reaching the target**: - According to the 2010 Chinese guidelines, among patients taking antihypertensive drugs, the proportion of blood pressure not reaching the target was 86.1%. - According to the 2017 ACC/AHA guidelines, this proportion increased to 96.7%, an increase of 10.6%. ### Research conclusions: - The new 2017 ACC/AHA guidelines will significantly increase the diagnosis rate of hypertension and the proportion of recommended antihypertensive drug treatment in rural areas of China. - The hypertension control rate is low, and more active management measures are needed to improve this situation. - This study provides important data support for the future prevention and treatment of hypertension in China. ### Discussion: - The prevalence of hypertension in China has increased significantly in the past few decades, especially in rural areas. - The implementation of the new guidelines will bring huge public health challenges, but it also provides an opportunity for healthcare providers and patients to discuss the value of non - drug treatment. - Improving the hypertension control rate is a severe challenge and requires multi - faceted efforts, including educational interventions, environmental improvements, and optimal allocation of medical resources.

Potential epidemiological impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on the Chinese population: a cross-sectional study in rural areas of Liaoning Province

Characteristics of High Risk People with Cardiovascular Disease in Chinese Rural Areas: Clinical Indictors, Disease Patterns and Drug Treatment

Prevalence and Treatment of Hypertension in China: Impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.

Prevalence, Awareness, Treatment & Control of Hypertension in Rural Liaoning Province, China.

Incidence and Predictors of Hypertension among Rural Chinese Adults: Results from Liaoning Province

The Prevalence of Prehypertension and Hypertension among Rural Adults in Liaoning Province of China

The Accelerating Epidemic of Hypertension among Rural Chinese Women: Results from Liaoning Province

Epidemiology of Hypertension and Associated with Risk Factors in Rural Areas in Changchun of China

Prevalence, Awareness, Treatment, and Control of Hypertension in Rural Adults from Liaoning Province, Northeast China

Hypertension in China: the Gap Between Policy and Practice

The Association of Stage 1 Hypertension, Defined by the 2017 ACC/AHA Guidelines, With Cardiovascular Events Among Rural Women in Liaoning Province, China

Prevalence and Risk Factors of the Rural Adult People Prehypertension Status in Liaoning Province of China.

Trends in Population Blood Pressure and Prevalence, Awareness, Treatment, and Control of Hypertension among Middle-Aged and Older Adults in a Rural Area of Northwest China from 1982 to 2010.

Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study

Ethnic Differences in the Incidence of Hypertension among Rural Chinese Adults: Results from Liaoning Province.

Risk Of Progression To Hypertension Across Baseline Blood Pressure In Nonhypertensive Participants Among Rural Chinese Adults: A Prospective Study

Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study

Association Between Blood Pressure Levels and Cardiovascular Deaths: a 20-Year Follow-Up Study in Rural China

The Rates and the Determinants of Hypertension According to the 2017 Definition of Hypertension by ACC/AHA and 2014 Evidence-Based Guidelines Among Population Aged ≥40 Years Old

Appropriateness of the 2017 ACC/AHA Guidelines: Applied to Data from the China National Stroke Screening and Prevention Project Study